PALANTIR TECHNOLOGIES INC CL A
Reported by Howard Hughes Medical Institute
Reported 64,567 shares, up 33,810 (109.9%) from the prior quarter.
Reported value 236.6%; share count 109.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-06-30 | 60117 |
| 2025-09-30 | 89021 |
| 2025-12-31 | 87098 |
| 2026-03-31 | 4499134 |
| 2026-06-30 | 3588419 |
| 2026-09-30 | 12077257 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 64,567 | +33,810 (109.9%) | 1.15% | $12,077,257 | 2026-11-16 | |
| Q2 2026 | Unchanged | 30,757 | 0 (0.0%) | 0.81% | $3,588,419 | 2026-08-14 | |
| Q1 2026 | Added | 30,757 | +30,267 (6176.9%) | 1.08% | $4,499,134 | 2026-05-15 | |
| Q4 2025 | Added | 490 | +2 (0.4%) | 0.05% | $87,098 | 2026-02-17 | |
| Q3 2025 | Added | 488 | +47 (10.7%) | 0.05% | $89,021 | 2025-11-14 | |
| Q2 2025 | New | 441 | +441 (0.0%) | 0.02% | $60,117 | 2025-08-14 |
Who else reported the position
3341 managers reported PALANTIR TECHNOLOGIES INC CL A for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Reduced | 189,782,108 | -35,585 | 0.52% | $35,498,743,233 | 9 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 146,760,154 | +622,640 | 0.58% | $27,451,486,806 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 104,326,819 | -163,649 | 0.57% | $19,514,331,494 | 24 qtrs |
| Invesco Ltd | Reduced | 70,174,299 | -264,218 | 1.03% | $13,126,102,638 | 24 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 56,111,466 | +776,498 | 0.54% | $10,467,531,889 | 24 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 50,500,594 | +223,785 | 0.43% | $9,446,136,108 | 3 qtrs |
| FMR LLC | Added | 48,981,219 | +26,412,610 | 0.4% | $9,161,937,007 | 24 qtrs |
| JPMorgan Chase & Co | Added | 40,457,805 | +10,962,831 | 0.41% | $7,564,396,359 | 25 qtrs |
| MORGAN STANLEY | Added | 34,454,271 | +432,984 | 0.33% | $6,444,671,719 | 25 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 22,203,197 | +14,483,094 | 0.42% | $4,153,109,000 | 25 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- CL A
Voting authority reported
- Sole
- 64,567
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.